{"pmid":32472948,"title":"Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy.","text":["Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy.","Cancer","Rolfo, Christian","Russo, Alessandro","de Miguel-Perez, Diego","32472948"],"journal":"Cancer","authors":["Rolfo, Christian","Russo, Alessandro","de Miguel-Perez, Diego"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472948","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/cncr.32983","keywords":["covid-19","sars-cov-2","cancer","cfdna","liquid biopsy"],"topics":["Mechanism","Treatment","Diagnosis","Prevention"],"weight":1,"_version_":1668255193369673728,"score":9.490897,"similar":[{"pmid":32466536,"title":"Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.","text":["Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.","Graphene-based materials are intriguing nanomaterials with applications ranging from nanotechnology-related devices to drug delivery systems and biosensing. Multifunctional graphene platforms were proposed for the detection of several typical biomarkers (i.e., circulating tumor cells, exosomes, circulating nucleic acids, etc.) in liquid biopsy, and numerous methods, including optical, electrochemical, surface-enhanced Raman scattering (SERS), etc., have been developed for their detection. Due to the massive advancements in biology, material chemistry, and analytical technology, it is necessary to review the progress in this field from both medical and chemical sides. Liquid biopsy is considered a revolutionary technique that is opening unexpected perspectives in the early diagnosis and, in therapy monitoring, severe diseases, including cancer, metabolic syndrome, autoimmune, and neurodegenerative disorders. Although nanotechnology based on graphene has been poorly applied for the rapid diagnosis of viral diseases, the extraordinary properties of graphene (i.e., high electronic conductivity, large specific area, and surface functionalization) can be also exploited for the diagnosis of emerging viral diseases, such as the coronavirus disease 2019 (COVID-19). This review aimed to provide a comprehensive and in-depth summarization of the contribution of graphene-based nanomaterials in liquid biopsy, discussing the remaining challenges and the future trend; moreover, the paper gave the first look at the potentiality of graphene in COVID-19 diagnosis.","Nanomaterials (Basel)","Cordaro, Annalaura","Neri, Giulia","Sciortino, Maria Teresa","Scala, Angela","Piperno, Anna","32466536"],"abstract":["Graphene-based materials are intriguing nanomaterials with applications ranging from nanotechnology-related devices to drug delivery systems and biosensing. Multifunctional graphene platforms were proposed for the detection of several typical biomarkers (i.e., circulating tumor cells, exosomes, circulating nucleic acids, etc.) in liquid biopsy, and numerous methods, including optical, electrochemical, surface-enhanced Raman scattering (SERS), etc., have been developed for their detection. Due to the massive advancements in biology, material chemistry, and analytical technology, it is necessary to review the progress in this field from both medical and chemical sides. Liquid biopsy is considered a revolutionary technique that is opening unexpected perspectives in the early diagnosis and, in therapy monitoring, severe diseases, including cancer, metabolic syndrome, autoimmune, and neurodegenerative disorders. Although nanotechnology based on graphene has been poorly applied for the rapid diagnosis of viral diseases, the extraordinary properties of graphene (i.e., high electronic conductivity, large specific area, and surface functionalization) can be also exploited for the diagnosis of emerging viral diseases, such as the coronavirus disease 2019 (COVID-19). This review aimed to provide a comprehensive and in-depth summarization of the contribution of graphene-based nanomaterials in liquid biopsy, discussing the remaining challenges and the future trend; moreover, the paper gave the first look at the potentiality of graphene in COVID-19 diagnosis."],"journal":"Nanomaterials (Basel)","authors":["Cordaro, Annalaura","Neri, Giulia","Sciortino, Maria Teresa","Scala, Angela","Piperno, Anna"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466536","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/nano10061014","keywords":["covid-19","sers","circulating nucleic acids","circulating tumor cells","exosomes","graphene","liquid biopsy"],"e_drugs":["Graphite"],"topics":["Diagnosis"],"weight":1,"_version_":1668167110087409664,"score":147.56871},{"pmid":32353474,"pmcid":"PMC7184998","title":"Genotyping coronavirus SARS-CoV-2: methods and implications.","text":["Genotyping coronavirus SARS-CoV-2: methods and implications.","The emerging global infectious COVID-19 disease by novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and the economy since it was identified in late December 2019 in China. The virus has gone through various pathways of evolution. To understand the evolution and transmission of SARS-CoV-2, genotyping of virus isolates is of great importance. This study presents an accurate method for effectively genotyping SARS-CoV-2 viruses using complete genomes. The method employs the multiple sequence alignments of the genome isolates with the SARS-CoV-2 reference genome. The single-nucleotide polymorphism (SNP) genotypes are then measured by Jaccard distances to track the relationship of virus isolates. The genotyping analysis of SARS-CoV-2 isolates from the globe reveals that specific multiple mutations are the predominated mutation type during the current epidemic. The proposed method serves an effective tool for monitoring and tracking the epidemic of pathogenic viruses in their global and local genetic variations. The genotyping analysis shows that the genes encoding the S proteins and RNA polymerase, RNA primase, and nucleoprotein, undergo frequent mutations. These mutations are critical for vaccine development in disease control.","Genomics","Yin, Changchuan","32353474"],"abstract":["The emerging global infectious COVID-19 disease by novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and the economy since it was identified in late December 2019 in China. The virus has gone through various pathways of evolution. To understand the evolution and transmission of SARS-CoV-2, genotyping of virus isolates is of great importance. This study presents an accurate method for effectively genotyping SARS-CoV-2 viruses using complete genomes. The method employs the multiple sequence alignments of the genome isolates with the SARS-CoV-2 reference genome. The single-nucleotide polymorphism (SNP) genotypes are then measured by Jaccard distances to track the relationship of virus isolates. The genotyping analysis of SARS-CoV-2 isolates from the globe reveals that specific multiple mutations are the predominated mutation type during the current epidemic. The proposed method serves an effective tool for monitoring and tracking the epidemic of pathogenic viruses in their global and local genetic variations. The genotyping analysis shows that the genes encoding the S proteins and RNA polymerase, RNA primase, and nucleoprotein, undergo frequent mutations. These mutations are critical for vaccine development in disease control."],"journal":"Genomics","authors":["Yin, Changchuan"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353474","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ygeno.2020.04.016","keywords":["2019-ncov","covid-19","genotyping","sars-cov-2","single-nucleotide polymorphism"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138495617335297,"score":75.30067},{"pmid":32292919,"pmcid":"PMC7151392","title":"The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer.","text":["The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer.","JACC CardioOncol","Ganatra, Sarju","Hammond, Sarah P","Nohria, Anju","32292919"],"journal":"JACC CardioOncol","authors":["Ganatra, Sarju","Hammond, Sarah P","Nohria, Anju"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292919","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaccao.2020.03.001","keywords":["ace-2, angiotensin-converting enzyme 2","acei, angiotensin converting enzyme inhibitor","arb, angiotensin receptor blocker","cdc, centers for disease control","covid-19","cvd, cardiovascular disease","coronavirus","coronavirus disease 2019, covid-19","mers-cov, middle east respiratory syndrome coronavirus","sars-cov-2","sars-cov-2, severe acute respiratory syndrome coronavirus 2","who, world health organization","cancer","cardio-oncology","cardiovascular disease"],"topics":["Treatment","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1666138494324441089,"score":74.190254},{"pmid":32469258,"title":"Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.","text":["Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.","PURPOSE: To report the presence of viral ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human retina in deceased patients with confirmed novel coronavirus disease 2019 (COVID-19). PATIENTS AND METHODS: Fourteen eyes of 14 deceased patients with confirmed COVID-19 disease were enucleated during autopsy. A sample of human retina was secured and fixed in RNAlater. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect three different viral RNA sequences (RdRp-gene, E-gene and Orf1 gene) of SARS-CoV-2. RESULTS: In three out of 14 eyes SARS-CoV-2 viral RNA was detected in the retina of deceased COVID-19 patients. As analysis for three different sequences (RdRp-gene, E-gene and Orf1 gene) revealed positive results in RT-PCR, the existence of SARS-CoV-2 viral RNA in human retina is proven according to the standards of the World-Health-Organization. CONCLUSION: Viral RNA of SARS-CoV-2 is detectable in the retina of COVID-19 patients.","Ocul Immunol Inflamm","Casagrande, Maria","Fitzek, Antonia","Puschel, Klaus","Aleshcheva, Ganna","Schultheiss, Heinz-Peter","Berneking, Laura","Spitzer, Martin S","Schultheiss, Maximilian","32469258"],"abstract":["PURPOSE: To report the presence of viral ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human retina in deceased patients with confirmed novel coronavirus disease 2019 (COVID-19). PATIENTS AND METHODS: Fourteen eyes of 14 deceased patients with confirmed COVID-19 disease were enucleated during autopsy. A sample of human retina was secured and fixed in RNAlater. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect three different viral RNA sequences (RdRp-gene, E-gene and Orf1 gene) of SARS-CoV-2. RESULTS: In three out of 14 eyes SARS-CoV-2 viral RNA was detected in the retina of deceased COVID-19 patients. As analysis for three different sequences (RdRp-gene, E-gene and Orf1 gene) revealed positive results in RT-PCR, the existence of SARS-CoV-2 viral RNA in human retina is proven according to the standards of the World-Health-Organization. CONCLUSION: Viral RNA of SARS-CoV-2 is detectable in the retina of COVID-19 patients."],"journal":"Ocul Immunol Inflamm","authors":["Casagrande, Maria","Fitzek, Antonia","Puschel, Klaus","Aleshcheva, Ganna","Schultheiss, Heinz-Peter","Berneking, Laura","Spitzer, Martin S","Schultheiss, Maximilian"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469258","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/09273948.2020.1770301","keywords":["ace-2","covid-19","rt-pcr","sars-cov-2","autopsy","retina"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1668420887159767040,"score":68.936005},{"pmid":32481719,"title":"The Role of MicroRNA in the Airway Surface Liquid Homeostasis.","text":["The Role of MicroRNA in the Airway Surface Liquid Homeostasis.","Mucociliary clearance, mediated by a coordinated function of cilia bathing in the airway surface liquid (ASL) on the surface of airway epithelium, protects the host from inhaled pathogens and is an essential component of the innate immunity. ASL is composed of the superficial mucus layer and the deeper periciliary liquid. Ion channels, transporters, and pumps coordinate the transcellular and paracellular movement of ions and water to maintain the ASL volume and mucus hydration. microRNA (miRNA) is a class of non-coding, short single-stranded RNA regulating gene expression by post-transcriptional mechanisms. miRNAs have been increasingly recognized as essential regulators of ion channels and transporters responsible for ASL homeostasis. miRNAs also influence the airway host defense. We summarize the most up-to-date information on the role of miRNAs in ASL homeostasis and host-pathogen interactions in the airway and discuss concepts for miRNA-directed therapy.","Int J Mol Sci","Mitash, Nilay","E Donovan, Joshua","Swiatecka-Urban, Agnieszka","32481719"],"abstract":["Mucociliary clearance, mediated by a coordinated function of cilia bathing in the airway surface liquid (ASL) on the surface of airway epithelium, protects the host from inhaled pathogens and is an essential component of the innate immunity. ASL is composed of the superficial mucus layer and the deeper periciliary liquid. Ion channels, transporters, and pumps coordinate the transcellular and paracellular movement of ions and water to maintain the ASL volume and mucus hydration. microRNA (miRNA) is a class of non-coding, short single-stranded RNA regulating gene expression by post-transcriptional mechanisms. miRNAs have been increasingly recognized as essential regulators of ion channels and transporters responsible for ASL homeostasis. miRNAs also influence the airway host defense. We summarize the most up-to-date information on the role of miRNAs in ASL homeostasis and host-pathogen interactions in the airway and discuss concepts for miRNA-directed therapy."],"journal":"Int J Mol Sci","authors":["Mitash, Nilay","E Donovan, Joshua","Swiatecka-Urban, Agnieszka"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32481719","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3390/ijms21113848","keywords":["rna-induced silencing complex","sars-cov-2","airway host defense","airway surface liquid","chronic obstructive pulmonary disease","coronavirus","cystic fibrosis","ion channels","mirna-mrna interaction","microrna"],"e_drugs":["Water"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668532114938658816,"score":66.58652}]}